These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36381714)

  • 1. Neuroleptic Malignant Syndrome From Oxcarbazepine and Topiramate Withdrawal: An Unusual Case.
    Dang S; Peteru S; Raja M; Askandaryan A; Vallejo G
    Cureus; 2022 Oct; 14(10):e29992. PubMed ID: 36381714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL; Taylor WH; Ware MR
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prochlorperazine-induced neuroleptic malignant syndrome.
    Tee ZJ
    Am J Emerg Med; 2024 Jul; 81():160.e1-160.e2. PubMed ID: 38575461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the Features of Neuroleptic Malignant Syndrome in Anti-NMDA Receptor Encephalitis: A Case-Control Study.
    Ramirez-Bermudez J; Restrepo-Martinez M; Espinola-Nadurille M; Martinez-Angeles V; Lopez-Hernandez JC; Hernandez-Vanegas LE; Martinez-Carrillo F; Ruiz-Garcia R; Rivas-Alonso V; Flores-Rivera J; Pollak TA
    J Acad Consult Liaison Psychiatry; 2024; 65(3):222-230. PubMed ID: 38151160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome after overdose of haloperidol - A case report.
    Kraaijvanger N; Mieloo T
    Toxicol Rep; 2024 Jun; 12():356-360. PubMed ID: 38560509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
    Musselman ME; Browning LA; Parker D; Saely S
    Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconsidering Rigidity in the Diagnosis of Neuroleptic Malignant Syndrome: A Case Report.
    El Khoury R; Kassab A; Dagher R; Javelot H; El Chammay R; Richa S
    J Psychiatr Pract; 2020 Jul; 26(4):320-323. PubMed ID: 32692129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid symptom control in neuroleptic malignant syndrome with electroconvulsive therapy: A case report.
    Katzell L; Beydler E; Dos Santos AS; Vijayvargiya R; Carr BR
    Front Psychiatry; 2023; 14():1143407. PubMed ID: 37032940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe Recurrence of Neuroleptic Malignant Syndrome: Usefulness of Dexmedetomidine for Antipsychotic Withdrawal.
    Maeda K; Ichiba T; Kashiwa K; Okazaki Y
    Cureus; 2023 Oct; 15(10):e47088. PubMed ID: 38022067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of neuroleptic malignant syndrome.
    Guerrero RM; Shifrar KA
    Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic Malignant Syndrome Associated with Valproate in an Adolescent.
    Yıldırım V; Direk MÇ; Güneş S; Okuyaz Ç; Toros F
    Clin Psychopharmacol Neurosci; 2017 Feb; 15(1):76-78. PubMed ID: 28138117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.
    Perry PJ; Wilborn CA
    Ann Clin Psychiatry; 2012 May; 24(2):155-62. PubMed ID: 22563571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant Catatonia Versus Neuroleptic Malignant Syndrome.
    Desai S; Hirachan T; Toma A; Gerolemou A
    Cureus; 2021 Jun; 13(6):e15818. PubMed ID: 34306883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
    Sokoro AA; Zivot J; Ariano RE
    Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical Neuroleptic Malignant Syndrome Precipitated by Clozapine and Quetiapine Overdose: A Diagnostic Challenge.
    Teo DCL; Wong HK; Tan SN
    Innov Clin Neurosci; 2018; 15(7-8):20-22. PubMed ID: 30254795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to benzodiazepines and the clinical course in malignant catatonia associated with schizophrenia: A case report.
    Ohi K; Kuwata A; Shimada T; Yasuyama T; Nitta Y; Uehara T; Kawasaki Y
    Medicine (Baltimore); 2017 Apr; 96(16):e6566. PubMed ID: 28422845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol-Induced Neuroleptic Malignant Syndrome: A Case Report.
    Fader JP; Walker Evans M; Lundgren AM; Sigmund TB; Allen TJ
    Cureus; 2024 Mar; 16(3):e57276. PubMed ID: 38686249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and therapeutic challenges in neuroleptic malignant syndrome: a severe medical case.
    Brogna P; Colasuonno R; Di Michele F; Paterniti AM; Talamo A; Ribolsi M; Jannini TB; Siracusano A; Niolu C
    Riv Psichiatr; 2020; 55(4):236-239. PubMed ID: 32724236
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.